Seek and destroy: improving PK/PD profiles of anticancer agents with nanoparticles-Reference-Cited by-同舟云学术

Seek and destroy: improving PK/PD profiles of anticancer agents with nanoparticles

Published:2018-05-24 Issue:6 Volume:11 Page:599-610
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Rodallec Anne¹,Fanciullino Raphaelle¹,Lacarelle Bruno¹,Ciccolini Joseph¹

Affiliation:

1. SMARTc Unit, Pharmacokinetics Laboratory, Inserm UMR U1068 Centre de Recherche en Cancérologie de Marseille, Aix-Marseille Universite, Marseille, France

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2018.1477586

Reference96 articles.

1. Cocktails for cancer with a measure of immunotherapy

2. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.

3. Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials

4. Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine

5. Managing Toxicities Associated With Colorectal Cancer Chemotherapy and Targeted Therapy

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and preparation of pH-sensitive cytotoxic liposomal formulations containing antitumor colchicine analogues for target release;Journal of Liposome Research;2023-10-23

2. A SWOT analysis of nano co-crystals in drug delivery: present outlook and future perspectives;RSC Advances;2023

3. Amphotericin B Nano-Assemblies Circumvent Intrinsic Toxicity and Ensure Superior Protection in Experimental Visceral Leishmaniasis with Feeble Toxic Manifestation;Vaccines;2023-01-01

4. Nanotherapeutics Plus Immunotherapy in Oncology: Who Brings What to the Table?;Pharmaceutics;2022-10-28

5. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics;WIREs Nanomedicine and Nanobiotechnology;2022-08-18